Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeymatm, a ...

In a combined network meta-analysis, infliximab and adalimumab had the greatest risk for serious infection in patients with plaque psoriasis.

Optimized Gel Formulation Demonstrates Clinical Success in Third Cohort of Patients PRINCETON, N.J., Dec. 17, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ...

The ustekinumab (Stelara; Janssen Biotech) biosimilar DMB-3115 (Imuldosa; Accord BioPharma) demonstrated clinical efficacy and safety comparable to the reference product through 52 weeks in a recent ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

A tattoo can trigger a psoriasis flare. These tips will help you reduce that risk and keep your tattoos looking good.

Learn how to pick the best cleansers when you have psoriasis, with expert advice and details on what ingredients to seek out — and which to avoid.

In patients with plaque psoriasis, family history and palmoplantar involvement were among the predictors of early super response to bimekizumab.

Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri ...

The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. This drugmaker has a strong ...

Psoriasis is a common chronic, recurrent, inflammatory, and systemic disease mediated by the immune system. According to the Guideline for the Diagnosis and Treatment of Psoriasis in China (2023 ...